Tessari Eben bought KNSA
August 5, 2025 · Form 4 insider transaction
Tessari Eben bought 25,896 shares of Kiniksa Pharmaceuticals International, plc at $11.97 per share, a transaction worth $310.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,896
Price
$11.97
Total value
$310.0K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateAugust 5, 2025
Filing dateAugust 7, 2025
Shares owned after177,893
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.